Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma
García Laraña, J.; Díaz Mediavilla, J.; Martínez, R.; Lahuerta, J.J.; Alegre, A.; Odriozola, J.; Sureda, A.; San Miguel, J.; De la Rubia, J.; Escudero, A.; Conde, E.; Bladé, J.; Cabrera, R.; Gastearena, J.; Besalduch, J.; Vidal, M.J.; Hernández, F.; Rifon, J.; Leon, A.; Mataix, R.; Parody, R.; Moraleda, J.M.; Solano, C.; de Pablos, J.M.; Sánchez, J.J.
Sangre 42(Suppl 1): 38-41
1997
ISSN/ISBN: 0036-4355 PMID: 9381300 Document Number: 479733
Document emailed within 1 workday
Related Documents
Alegre, Aán.; Granda, Aón.; Martínez-Chamorro, C.; Díaz-Mediavilla, Jín.; Martínez, R.; García-Laraña, Jé.; Lahuerta, J-José.; Sureda, A.; Bladé, J.; de la Rubia, J.; Fernández-Rañada, Jé.Maria.; San Miguel, Jús. 2002: Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry Haematologica 87(6): 609-614Pileri, A.; Tarella, C.; Bregni, M.; Boccadoro, M.; Siena, S.; Caracciolo, D.; Bonadonna, G.; Gianni, A.M. 1990: GM-CSF-exposed peripheral blood progenitors as sole source of stem cells for autologous transplantation in two patients with multiple myeloma Haematologica 75(Suppl 1): 79-82
Kmonícek, M.; Jebavý, L.; Lánská, M.; Zák, P.; Malý, J.; Maisnar, V. 2000: The treatment of multiple myeloma with an allogeneic peripheral blood stem cell transplantation using a non-myeloablative conditioning regimen Vnitrni Lekarstvi 46(7): 377-383
Duncan, N.; Hewetson, M.; Powles, R.; Raje, N.; Mehta, J. 1996: An economic evaluation of peripheral blood stem cell transplantation as an alternative to autologous bone marrow transplantation in multiple myeloma Bone Marrow Transplantation 18(6): 1175-1178
Dreyfus, F.; Ribrag, V.; Leblond, V.; Ravaud, P.; Melle, J.; Quarre, M.C.; Pillier, C.; Boccaccio, C.; Varet, B. 1995: Detection of malignant B cells in peripheral blood stem cell collections after chemotherapy in patients with multiple myeloma Bone Marrow Transplantation 15(5): 707-711
Majolino, I.; Marcenò, R.; Buscemi, F.; Scimè, R.; Vasta, S.; Indovina, A.; Pampinella, M.; Catania, P.; Santoro, A. 1995: Mobilization of circulating progenitor cells in multiple myeloma during VCAD therapy with or without rhG-CSF Haematologica 80(2): 108-114
Piatkowska-Jakubas, B.; Skotnicki, A.B.; Blicharski, J. 1988: Possibility of using interferon in the treatment of multiple myeloma Przeglad Lekarski 45(10): 747-750
Hołowiecki, J.; Wojnar, J.; Markiewicz, M.; Wacławik, A.; Jagoda, K.; Kamińska, H.; Kachel, L.; Wojciechowska, M.; Kata, D. 1995: Autologous peripheral blood stem and progenitor cells transplantation as a valid treatment approach in recurrent, refractory lymphoma Archivum Immunologiae et Therapiae Experimentalis 43(3-4): 191-194
Takahashi, T.; Makiguchi, Y.; Hinoda, Y.; Kakiuchi, H.; Nakagawa, N.; Imai, K.; Yachi, A. 1994: Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient Journal of Immunology 153(5): 2102-2109
Gertz, M.A.; Pineda, A.A.; Chen, M.G.; Letendre, L.; Greipp, P.R.; Solberg, L.A.; Witzig, T.E.; Garton, J.P.; Inwards, D.J.; Litzow, M.R. 1995: Refractory and relapsing multiple myeloma treated by blood stem cell transplantation American Journal of the Medical Sciences 309(3): 152-161
Weber, D.M. 2003: Strategies in treating newly diagnosed or untreated multiple myeloma patients. from the Multiple Myeloma Research Foundation Oncology 17(6): 765-767
Adam, Z.; Klabusay, M.; Vorlícek, J.; Hájek, R. 1997: Detection of myeloma cells in the peripheral blood using flow cytometry Vnitrni Lekarstvi 43(9): 592-598
Urbano-Ispizua, A.; Solano, C.; Brunet, S.; Hernández, F.; Sanz, G.; Alegre, A.; Petit, J.; Besalduch, J.; Vivancos, P.; Díaz, M.A.; Moraleda, J.M.; Carreras, E.; Ojeda, E.; de la Rubia, J.; Benet, I.; Domingo-Albós, A.; García-Conde, J.; Rozman, C. 1996: Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. allo-PBPCT Spanish Group Bone Marrow Transplantation 18(1): 35-40
Champlin, R.E. 1996: Peripheral blood progenitor cells: a replacement for marrow transplantation? Seminars in Oncology 23(2 Suppl 4: 15-21
Kedar, I.; Segal, A. 1995: Interferon in multiple myeloma--does it pay? Israel Journal of Medical Sciences 31(10): 635-637
Stadtmauer, E.A. 2010: Tailoring initial treatment for newly diagnosed, transplantation-eligible multiple myeloma Oncology 24(3 Suppl 2: 7-13
Schmitz, N.; Bacigalupo, A.; Labopin, M.; Majolino, I.; Laporte, J.P.; Brinch, L.; Cook, G.; Lambertenghi-Deliliers, G.; Lange, A.; Rozman, C.; Garcia-Conde, J.; Finke, J.; Domingo-Albos, A.; Gratwohl, A. 1996: Transplantation of allogeneic peripheral blood progenitor cells--the EBMT experience Bone Marrow Transplantation 17(Suppl 2): S40-S46
Pasqualetti, P.; Casale, R.; Collacciani, A.; Colantonio, D. 1989: Evaluation of a morphologic staging method (myeloma progression score) in multiple myeloma Medicina 9(3): 280-282
Barlogie, B.; Alexanian, R. 1989: Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma Cancer Research 49(24 Pt 1): 7172-7175
Vítek, A.; Sajdová, J.; Hrabánek, J.; Kobylka, P.; Korínková, P.; Gasová, Z.; Loudová, M.; Cukrová, V.; Dolezalová, L.; Marinov, J.; Sieglová, Z.; Hrubá, A. 1998: Transplantation of allogeneic peripheral blood progenitor cells--a single centre experience Bone Marrow Transplantation 22(Suppl 4): S73-S76